The global male hypogonadism market was valued at $2,594 million in 2015, and is estimated to reach $3,233 million by 2022, growing at a CAGR of 3.1% during the analysis period.
Globally, the prevalence for hypogonadism among men is on a rise at a rapid rate, and according to multiple studies, only 10-15% of patients receive treatment for this condition. Male hypogonadism is a medical condition characterized by the inability of the testes to produce sufficient amount of testosterone, which is responsible for the development of secondary sexual characteristics. This results in underdevelopment of muscles, impaired growth of body hair, development of breast tissues, and lack of deepening of the voice.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=26990
Major factors that drive the market growth include high incidence of hypogonadism; rise in geriatric population; growth in awareness of hypogonadism & its treatment options; and increased risk of developing hypogonadism due to increased incidence of chronic lifestyle diseases such as diabetes and obesity. In March 2015, FDA issued cautions & warnings against use of testosterone products as a therapy, and ordered the manufacturers to change labels & add cautions on their packaging. From recent studies conducted by the FDA, there is a high risk of acquiring cardiovascular diseases due to the use of TRT, thus impeding the market growth during the forecast period. However, novel treatment options that are under developmental stage have shown positive results in terms of efficacy, and they are expected to have lesser or no side effects. Therefore, these advancements are anticipated to provide new opportunities in the future.
The global male hypogonadism market is segmented based on therapy, drug delivery, type, and geography. Based on therapy, it is bifurcated into testosterone replacement therapy (TRT), and gonadotropin and gonadotropin-releasing hormones therapy. Gonadotropin and gonadotropin-releasing hormones therapy is further sub-classified into LH, FSH, human chorionic gonadotropin (hCG), and GnRH. Based on drug delivery, it is classified into topical gels, injectables, transdermal patches, and others. Based on type, it is categorized into Klinefelter’s syndrome, Kallmann syndrome, pituitary disorders, and others. Based on geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
MALE HYPOGONADISM MARKET KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market, with current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis by therapy helps in understanding the various types of therapies used for the treatment of hypogonadism.
Comprehensive analysis of geographical regions is provided, which helps in determining the prevailing opportunities in these geographies.
Key players within the market are profiled and their strategies are analyzed thoroughly to determine competitive outlook of the global market.
LIST OF KEY PLAYERS PROFILED IN THE REPORT
AbbVie Inc.
Allergan plc
Astrazeneca plc
Bayer AG.
Eli Lilly and Company Ltd.
Endo International plc.
Merck & Co., Inc.
Ferring
Finox Biotech
IBSA Institut Biochimque SA
Laboratoires Genevrier
Teva Pharmaceutical Industries Ltd.
Download Free Sample of This Strategic Report:https://reportocean.com/industry-verticals/sample-request?report_id=26990
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Lipocine Inc.
Pfizer Inc.
Aytu Biosciences
Diurnal Group PLC
Hyundai Pharmaceuticals Co Ltd.
Perrigo Company plc
Novus Biologicals, LLC
MALE HYPOGONADISM MARKET KEY MARKET SEGMENTS
BY THERAPY
Testosterone Replacement Therapy
Gonadotropin and Gonadotropin-Releasing Hormones Therapy
Luteinizing Hormone (LH)
Follicle-Stimulating Hormone (FSH)
Human Chorionic Gonadotropin (hCG)
Gonadotropin-Releasing Hormone (GnRH)
BY DRUG DELIVERY
Topical Gels
Injectables
Transdermal Patches
Others
BY TYPE
Klinefelter’s Syndrome
Kallmann Syndrome
Pituitary Disorders
Others
BY GEOGRAPHY
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Rest of Europe
Asia-Pacific
Japan
India
China
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
To Get More Business Strategies For Request Sample Report: https://reportocean.com/industry-verticals/sample-request?report_id=26990
Table of Contents:
- Introduction and Scope
- Definition and Forecast Parameters
- Methodology and Forecast Parameters
- Information Sources
- Latest Trends Summary
- Regional Trends
- Product Trends
- End-Use Trends
- Business Trends
- Industry Insights
- Industry Fragmentation
- Industry Landscape
- Vendor Matrix
- Technological and Innovative Landscape
- Market by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
- Company Profiles
- Company Overview
- Financial Elements
- Product Landscape
- SWOT Analysis
- Systematic Outlook
Why is Our research important?
- Your research helps in understanding the current market dynamics, trends, and growth prospects of the patient engagement solutions market.
- This knowledge is crucial for businesses, investors, and stakeholders to make informed decisions and develop effective strategies.
- By analyzing the market landscape, identifying key market players, and evaluating market segments and regions, your research helps in identifying potential business opportunities within the patient engagement solutions market.
- Your research report provides forecasts and projections for the future growth of the patient engagement solutions market.
- This helps businesses in estimating market potential, assessing market risks, and planning for future investments and initiatives.
- Your research includes a competitive landscape analysis, highlighting the key players in the patient engagement solutions market and their strategies.
- This information assists businesses in understanding their competitors, their market position, and their strengths and weaknesses. It also helps in benchmarking and developing competitive strategies.
- Your research provides insights into the latest industry trends, technological advancements, and regulatory developments related to patient engagement solutions.
- This information helps businesses stay updated with the industry landscape and adapt to the changing market conditions.
- By providing comprehensive and reliable data, analysis, and insights, your research serves as a valuable resource for decision-making.
- It helps businesses, investors, and stakeholders in making well-informed decisions regarding market entry, product development, partnerships, investments, and other strategic initiatives.
- This information enables businesses to target specific areas for growth and expansion.
Key Questions the Report Discusses
- What essential elements emerged from both primary and secondary research?
- What will the market’s future potential be?
- Who examines the market report’s complete outcome?
- What obstacles and problems face the growth of an industry?
- What does supply chain analysis for products and market size, share mean?
- Which of the possible manufacturers is still operating in the market?
- What are the advantages, benefits, and applications of the product’s features?
- What are the main trends and influencing factors?
Request full Report: https://reportocean.com/industry-verticals/sample-request?report_id=26990
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1888 212 3539 (US – TOLL FREE)
Email: sales@reportocean.com
Visit our news website: https://reportocean.com